LHC Group (NASDAQ:LHCG) PT Raised to $136.00

LHC Group (NASDAQ:LHCG) had its price objective increased by UBS Group from $133.00 to $136.00 in a report released on Monday morning, BenzingaRatingsTable reports. UBS Group currently has a buy rating on the health services provider’s stock.

A number of other research firms have also recently commented on LHCG. Zacks Investment Research raised shares of LHC Group from a hold rating to a buy rating and set a $124.00 price target for the company in a research note on Thursday, September 19th. Royal Bank of Canada set a $135.00 price target on shares of LHC Group and gave the stock a buy rating in a research note on Friday, August 9th. Oppenheimer lifted their price target on shares of LHC Group from $125.00 to $146.00 and gave the stock an outperform rating in a research note on Friday, August 9th. Barclays lifted their price target on shares of LHC Group from $113.00 to $120.00 and gave the stock an equal weight rating in a research note on Friday, August 9th. Finally, BidaskClub cut shares of LHC Group from a strong-buy rating to a buy rating in a research note on Tuesday, September 17th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and an average price target of $130.00.

Shares of NASDAQ:LHCG opened at $113.78 on Monday. LHC Group has a 52 week low of $80.84 and a 52 week high of $129.37. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.16. The firm has a fifty day simple moving average of $119.47 and a two-hundred day simple moving average of $116.07. The stock has a market capitalization of $3.66 billion, a P/E ratio of 32.05, a PEG ratio of 1.92 and a beta of 0.85.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.06. LHC Group had a net margin of 4.20% and a return on equity of 8.83%. The firm had revenue of $517.84 million during the quarter, compared to analysts’ expectations of $524.24 million. During the same period in the previous year, the company earned $0.84 EPS. The firm’s revenue for the quarter was up 3.2% compared to the same quarter last year. On average, analysts expect that LHC Group will post 4.34 earnings per share for the current year.

A number of institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. boosted its position in LHC Group by 5.9% in the 2nd quarter. BlackRock Inc. now owns 4,960,615 shares of the health services provider’s stock valued at $593,191,000 after buying an additional 274,262 shares during the period. Vanguard Group Inc. boosted its position in LHC Group by 0.5% in the 2nd quarter. Vanguard Group Inc. now owns 3,111,588 shares of the health services provider’s stock valued at $372,084,000 after buying an additional 14,591 shares during the period. FMR LLC boosted its position in LHC Group by 2.4% in the 1st quarter. FMR LLC now owns 1,151,105 shares of the health services provider’s stock valued at $127,612,000 after buying an additional 27,272 shares during the period. Invesco Ltd. boosted its position in LHC Group by 148.4% in the 2nd quarter. Invesco Ltd. now owns 996,291 shares of the health services provider’s stock valued at $119,136,000 after buying an additional 595,208 shares during the period. Finally, Northern Trust Corp boosted its position in LHC Group by 0.8% in the 2nd quarter. Northern Trust Corp now owns 539,174 shares of the health services provider’s stock valued at $64,474,000 after buying an additional 4,035 shares during the period. 90.15% of the stock is owned by institutional investors.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Read More: Forex

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.